Efficiency, equity, and budgetary policies: Informing decisions using mathematical programming

Medical Decision Making

Volumn 27, Issue 2, 2007, Pages 128-137

  Epstein, David M ^a   Chalabi, Zaid ^b   Claxton, Karl ^b   Sculpher, Mark ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b NONE

Author keywords

Cost benefit analysis; Cost effectiveness analysis; Mathematical programming; Resource allocation

Indexed keywords

ARTICLE; BUDGET; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE POLICY; HEALTH CARE SYSTEM; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; RESOURCE ALLOCATION;

BUDGETS; EFFICIENCY, ORGANIZATIONAL; HEALTH EXPENDITURES; HEALTH POLICY; HUMANS; MODELS, ECONOMETRIC; QUALITY-ADJUSTED LIFE YEARS; RESOURCE ALLOCATION;

EID: 34147128539     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X06297396     Document Type: Article

References (29)

1. Johannesson M., Weinstein M. On the decision rules of cost-effectiveness analysis. J Health Econ. 1993 ; 12: 459 - 67.
2. Birch S., Gafni A. Economics and the evaluation of health care programmes: generalisability of methods and implications for generalisability of results. Health Policy. 2003 ; 64 (2). 207 - 19.
3. Stinnett AA, Paltiel AD Mathematical programming for the efficient allocation of health care resources. J Health Econ. 1996 ; 15 (5). 641 - 53.
4. Rawlins M., Culyer A. National Institute for Clinical Excellence and its value judgements. BMJ. 2004 ; 329: 224 - 7.
5. Birch S., Gafni A. The NICE approach to technology assessment: an economics perspective. Health Care Manage Sci. 2004 ; 7: 35 - 41.
6. Laska EM, Meisner M., Siegel C., Stinnett AA Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence. Health Econ. 1999 ; 8 (2). 171 - 4.
7. Al MJ, Teenstra TL, van Hout BA Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty. Health Econ. 2005 ; 14: 655 - 67.
8. Elbasha EH, Messonnier ML Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale. Health Econ. 2004 ; 13 (1). 21 - 35.
9. Earnshaw SR, Dennett SL Integer/linear mathematical programming models-a tool for allocating healthcare resources. Pharmacoeconomics. 2003 ; 21 (12). 839 - 51.
10. Sendi P., Al MJ Revisiting the decision rule of cost-effectiveness analysis under certainty and uncertainty. Soc Sci Med. 2003 ; 57 (6). 969 - 74.
11. Sendi P., Al MJ, Gafni A., Birch S. Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources. Soc Sci Med. 2003 ; 57 (11). 2207 - 15.
12. Earnshaw SR, Richter A., Sorensen SW, et al. Optimal allocation of resources across four interventions for type 2 diabetes. Med Decis Making. 2002 ; 22 (5). S80 - 91.
13. Zaric GS, Brandeau ML Optimal investment in a portfolio of HIV prevention programs. Med Decis Making. 2001 ; 21 (5). 391 - 408.
14. Brandeau ML, Zaric GS, Richter A. Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis. J Health Econ. 2003 ; 22 (4). 575 - 98.
15. Yan Wang L., Haddix AC, Teutsch AM, Caldwell B. The role of resource allocation models in selecting clinical preventive services. Am J Manage Care. 1999 ; 5 (4). 445 - 54.
16. Cromwell DA, Viney R., Halsall J., Hindle D. Linking measures of health gain to explicit priority setting by an area health service in Australia. Soc Sci Med. 1998 ; 47 (12). 2067 - 74.
17. Wolfram S. The Mathematica Book, Fifth Edition. Champaign (IL). Wolfram Media/Cambridge University Press ; 2003.
18. Devlin N., Parkin D. Does NICE have a cost-effectiveness threshold and what other factors influence it? A binary choice analysis. Health Econ. 2004 ; 13: 437 - 52.
19. Maynard A., Bloor K., Freemantle N. Challenges for the National Institute for Clinical Excellence. BMJ. 2004 ; 329: 227 - 9.
20. Warren E., Weatherley-Jones E., Chilcott J., Beverely C. The Clinical and Cost-Effectiveness of Long-Acting Insulin Analogue, Insulin Glargine. NICE Technology Appraisal 53. London: NICE ; 2002.
21. Knight C., Hind D., Brewer N., Abbott V. Rituximab (MabThera) for Aggressive non-Hodgkin's Lymphoma: Systematic Review. NICE Technology Appraisal 65. London: NICE ; 2003.
22. Turner D., Wailoo A., Nicholson K., Cooper N., Sutton A., Abrams K. Systematic Review and Economic Decision Modelling for the Prevention and Treatment of Influenza A and B: NICE Technology Appraisal 58. London: NICE ; 2002.
23. NICE. Retrieved from http:\www.nice.org.uk.
24. Nemhauser GL WL. Integer and Combinatorial Optimization: New York: John Wiley; 1999.
25. Koppe M., Weismantel R. An algorithm for mixed integer optimization. Math Progr Series B. 2003 ; 98: 281 - 307.
26. Richard Jpp, de Farias IR, Nemhauser GL Lifted inequalities for 0-1 mixed integer programming: basic theory and algorithms. Math Program, Series B. 2003 ; 98: 89 - 113.
27. van Zon AH, Kommer GJ Patient flows and optimal healthcare resource allocation at the macro-level: a dynamic linear programming approach. Health Care Manage Sci. 1999 ; 2 (2). 87 - 96.
28. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ. 1999 ; 18 (3). 341 - 64.
29. Ades AE, Lu G., Claxton K. Expected value of sample information calculations in medical decision modeling. Med Decis Making. 2004 ; 24: 207 - 27.